Use of linezolid in infants and children: A retrospective multicentre study of the Italian society for paediatric infectious diseases

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 10, 2011, Pages 2393-2397

  Garazzino, Silvia ^a   Krzysztofiak, Andrzej ^b   Esposito, Susanna ^c   Castagnola, Elio ^d   Plebani, Alessandro ^e   Galli, Luisa ^f   Cellini, Monica ^g   Lipreri, Rita ^h   Scolfaro, Carlo ^a   Bertaina, Chiara ^a   Calitri, Carmelina ^a   Bozzola, Elena ^b   Lancella, Laura ^b   Quondamcarlo, Anna ^b   Bosis, Samantha ^c   Pugni, Lorenza ^c   Losurdo, Giuseppe ^d   Soresina, Annarosa ^e   De Gaudio, Marina ^f   Mariotti, Ilaria ^g   Mancini, Luca ^h   Gabiano, Clara ^a   Tovo, Pier Angelo ^a   more..

^a REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d G GASLINI INSTITUTE   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

^f UNIVERSITY OF FLORENCE   (Italy)

^g UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^h OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Anaemia; Oxazolidinones; Paediatrics

Indexed keywords

LINEZOLID;

ADOLESCENT; AGE; ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BLOODSTREAM INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; ENDOCARDITIS; ENTEROCOCCAL INFECTION; GRAM POSITIVE INFECTION; HUMAN; LIVER FUNCTION TEST; MULTICENTER STUDY; NEUTROPENIA; PANCREATITIS; PNEUMONIA; RASH; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; SKIN INFECTION; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE; VOMITING;

ACETAMIDES; ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; ITALY; MALE; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; OXAZOLIDINONES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80052897934     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr285     Document Type: Article

References (24)

1. Moellering RC. Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med 2003; 138: 135-42.
2. Wilcox MH. Update on linezolid: the first oxazolidinone antibiotic. Expert Opin Pharmacother 2005; 6: 2315-26.
3. Alcalà L, Ruiz-Serrano MJ, Pérez-Fernàndez Turégano C et al. In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs. Antimicrob Agents Chemother 2003; 47: 416-7.
4. Schecter GF, Scott C, True L et al. Linezolid in the treatment of multidrug-resistant tuberculosis. Clin Infect Dis 2010; 50: 49-55.
5. Wallace RJ Jr, Brown-Elliot BA, Ward SC et al. Activities of linezolid against rapidly growing mycobacteria. Antimicrob Agents Chemother 2001; 45: 764-7.
6. Peters J, Kondo KL, Lee RK et al. In vitro activity of oxazolidinones against Mycobacterium avium complex. J Antimicrob Chemother 1995; 35: 675-9.
7. Nannini EC, Keating M, Binstock P et al. Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine. J Infect 2002; 44: 201-3.
8. Garazzino S, Tovo PA. Clinical experience with linezolid in infants and children. J Antimicrob Chemother 2011; 66 Suppl 4: iv23-41.
9. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement M100-S18. CLSI, Wayne, PA, USA, 2008.
10. Metaxas EI, Falagas ME. Update on the safety of linezolid. Expert Opin Drug Saf 2009; 8: 485-91.
11. Gerson SL, Kaplan SL, Bruss JB et al. Hematologic effects of linezolid: summary of clinical experience. Antimicrob Agents Chemother 2002; 46: 2723-6.
12. Bressler AM, Zimmer SM, Gilmore JL et al. Peripheral neuropathy associated with prolonged use of linezolid. Lancet Infect Dis 2004; 4: 528-31.
13. Soriano A, Miro O, Mensa J. Mitochondrial toxicity associated with linezolid. N Engl J Med 2005; 353: 2305-6.
14. Kaplan SL, Patterson L, Edwards KM et al. for the Linezolid Pediatric Pneumonia Study Group. Linezolid for the treatment of community-acquired pneumonia in hospitalized children. Pediatr Infect Dis J 2001; 20: 488-94.
15. Kaplan SL, Deville JG, Yogev R et al. for the Linezolid Pediatric Study Group. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. Pediatr Infect Dis J 2003; 22: 677-86.
16. Wible K, Tregnaghi M, Bruss J et al. Linezolid versus cefadroxil in the treatment of skin and skin structure infections in children. Pediatr Infect Dis J 2003; 22: 315-22.
17. Fleishaker DI, Anderson DC, Bruss JB et al. Clinical efficacy of linezolid (LZD) in the treatment of otitis media. In: Abstracts of the Thirty-eighth Annual Meeting of the IDSA. Abstract 65. Clin Infect Dis 2000; 31: 224.
18. Deville JG, Adler S, Azimi PH et al. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates. Pediatr Infect Dis J 2003; 22 Suppl: S158-63.
19. Meissner HC, Townsend T, Wenman W. Hematologic effects of linezolid in young children. Pediatr Infect Dis J 2003; 22 Suppl: S186-92.
20. Linam WM, Wesselkamper K, Gerber MA. Peripheral neuropathy in an adolescent treated with linezolid. Pediatr Infect Dis J 2009; 28: 149-51.
21. Brennan K, Jones BL, Jackson L. Auditory nerve neuropathy in a neonate after linezolid treatment. Pediatr Infect Dis J 2009; 28: 169.
22. Javaheri M, Khurana RN, O'Hearn TM et al. Linezolid-induced optic neuropathy: a mitochondrial disorder? Br J Ophthalmol 2007; 91: 111-5.
23. Anger HA, Dworkin F, Sharma S et al. Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06. J Antimicrob Chemother 2010; 65: 775-83.
24. Senneville E, Legout L, Valette M et al. Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study. J Antimicrob Chemother 2004; 54: 798-802.